Production of Nervonic acid in Brassica carinata for Industrial and
Transcription
Production of Nervonic acid in Brassica carinata for Industrial and
Production of Nervonic acid in Brassica carinata for Industrial and Health Applications Elizabeth-France Marillia & David C.Taylor ACRD-NRC April 2014 Bio-Based Specialized Chemicals Program-ACRD Overview • NRC and its new RTO structure & mandate • Life Science programs and industrial oils at NRC • Nervonic acid: functions, uses and production • Production in Brassica carinata: a Proof of Concept • Future steps and collaboration with the industry 2 Saskatoon About NRC IRAP • 2012-13 budget: $774M Research facilities • Over 4,000 employees and 650 volunteer and independent visitors • Wide variety of disciplines and broad array of services and support to industry 3 New Research Technology Organization (RTO) model • Vision: oTo be the most effective research and technology organization in the world and stimulate sustainable domestic prosperity • Mission: oWork with clients and partners to provide innovation support, strategic research and technical services (fee for services). oBe dedicated to building economic competitiveness and improving national productivity 4 NRC Life Sciences Research Life Sciences Aquatic and Crop Resource Development Human Health Therapeutics National Research Natural Health Products Algal Carbon Capture Wheat Bio-based Specialty Chemicals Crop Platform Technologies Biologics Vaccines Medical Devices NATURAL HEALTH PRODUCTS 5 Oil Seed Crops at NRC From Arabidopsis to Canola to Brassica carinata.... 30+ years of R&D on industrial oils and their applications Source: Wikipedia 6 Nervonic Acid 24:1 15 (cis-tetracos-15- enoic acid) -9 Produced by elongation of erucic acid 22:1 Physiological Functions • Physiological activity of nervonic acid discovered only 35 years ago • Necessary for development and maintenance of brain tissue & function: o Component of myelin sheath. Serves to speed conduction of nerve impulses o Maintains integrity & regulates function of Ca2+ ion channeling in cell membranes of nerve tissues o Thought to play a major role in memory o Role in postponing senility ? Pharmacological Indications Symptomatic treatment of: • De-myelinating diseases: Multiple Sclerosis, Parkinson, ALD • Schizophrenia: nervonic acid levels low in these patients • Deficiencies associated w neurological disorders: Alzheimer’s • HIV ? Nervonic acid inhibits HIV-1 Reverse Transcriptase • Many applications in nutritional markets (senility, memory aid etc.) • Treatments of arthritis, liver diseases and obesity Dietary Supplements • Babies/infants during the myelinating age. Baby foods/formulas (Hangzhou Sweetant Biotech) • Pre-term babies, no longer benefiting from maternal nutritionPregnant/lactating women • High-level training adults/athletes: enriched energy supplements with neuro-protective effect . 10 Industrial Applications 1- Biofuels & Surfactants • Next generation of alternative fuels: ARA Biofuels ISOCONVERSION: ReadiJet, Readi Diesel. Test flight with NRC in 2012 • “Green Surfactants”: Enhance Oil Recovery (EOR) for crude oil (Oil Chem Technologies). VLCFAs feedstocks used to reduce water & energy consumption during bitumen recovery & processing 11 Industrial Applications 2- Bioplastics and Polymers • Specialized polyamides, polyesters, polyols: Feedstock for diacid production in the bioplastic industry (Phytowelt Green Technologies; Mitsubishi) • Paving bed polymers (low temp. stabilization): Feedstock for moisture displacement additives in asphalt paving sealers (SWEPCO) 12 Others Industrial Applications Source Globalgrind • Cosmetics; hair dyeing; nail varnish (L’Oreal, Novance) • Medical: biological diagnosis (Konica); improved vaccine composition (Eurocine vaccines); • Photosensitive semiconductors (Samsung); superconductive wire (Hitachi) • Gels and films (YOUTEC) • Recording medium (HP) • Coating oil (Nalso) and ink (JNC) 13 Natural Sources for Nervonic Acid Nervonic acid content (mg/100g) Plant sources Brassica oilseeds Flaxseed Sesame seeds Macademia nuts Tropaeolum speciosum Lunaria (money plant) Cardamine graeca Acer (Purpleblow maple) Borage Sinapis alba Hemp 69-83 64 35 18 10 8 5.4 2.3 Indigofera tinctoria (indigo) Animal sources King Salmon (Chinook) Sockeye salmon Cerebroside extracts Pseudaxinella cf. lunaecharta 14 140 40 Nervonic Acid Suppliers and Market Values Some Examples Suppliers Product Market value US$/Kg Shanghi Soyoung Biotechnology nervonic acid food additives 1-27 Shaanxi Pioneer Biotech Co natural nervonic acid 300-400 Wuxi Cima Science Co 10-1000 nervonic acid powder Hangzhou Boduo Industrial nervonic acid capsules Trade Co 15 1500-2000 Production of Nervonic Acid in Brassica Rationale: High Erucic Acid (HEA) Brassica oilseeds contain traces of 24:1 in the seed oil because of…... the absence of an elongase (KCS condensing enzyme) specific for converting 22:1 to 24:1. Goal: Isolation & characterization of key gene(s) for the production of high levels of nervonic acid in Brassica oilseed platform crops Target KCS Gene Source Cardamine graeca (bittercress) 15cm 1 cm 1 mm The seed oil has 43 to 54% nervonic acid Expression of C. graeca KCS in Brassica carinata NAPIN CG KCS transform NOS Brassica carinata [ Ethiopian mustard ] Why B. carinata? ● Excellent “vehicle crop” for HEA Brassica work; 22:1 ca 35-38%; 30% oil; Yields 2,500 kg / ha ● Highly transformable (up to 50%) ● Low out-crossing ● Highly resistant to fungal diseases; weed tolerant ● Suitable for growth in drier regions Confined Field Trials (Saskatchewan) % 18:1c9 % 20:1c11 % 22:1c13 % 24:1c15 45.00 40.00 35.00 30.00 25.00 20.00 15.00 10.00 5.00 0.00 Card KCS: B car Transgenics CONTROLS MUFAs in B. carinata transformants Wild Type Control 18:1 20:1 22:1 Transgenic Control 24:1 Cardamine B. carinata Transgenic Line 45% 24:1 Oil retains essential FAs: 25-30% -3 (18:3) + -6 (18:2) Mono-Unsaturated FAs Elongation What we can do in a Brassica industrial platform crop 18:1 20:1 22:1 24:1 26:1 FA: oleic eicosenoic erucic nervonic ximenic Source: Teesdalia Crambe Cardamine Confidential NRC IP: Patent Patent Patent PSIA 28:1 ? Ability to tailor oil profiles for specific industrial & health applications 21 Uses of Industrial Oilseeds B carinata VLCFA OILS & APPLICATIONS VLCFA 20:1c11 22:1c13 24:1c15 26:1c17 JET FUELS EOR BIOPLASTICS NEURO HEALTH Future steps and collaborations 23 Next generation: Ultra-High Nervonic Carinata (UHN) oil What do we have? High-Nervonic carinata line: ~45% nervonic acid and essential FA profile of WT 17 g/100g seed; > any other seed source (~0.08g) Market demand ? An improved UHN carinata line (>80% 24:1) Why? Less purification required for industrial applications where high PUFAs not desired How? Produce seed oils (TAG) with nervonic moieties at all 3 sn- positions on the glycerol backbone Tri- nervonoyl TAG sn-1 Nervonic sn-2 Nervonic sn-3 25 Nervonic Additional Genetic Modifications to Achieve Commercial Success •Over-express LPAT2 for esterification at the sn2 position •Health applications: reduce residual erucic acid from 7% to <2% ? or start with a low erucic B carinata? •Industrial applications: silence endogenous B carinata KCS and over-express KCS genes from Teesdalia (20:1) and Cardamine (24:1) in tandem? 26 Mono-Unsaturated FAs Elongation 18:1 27 20:1 FA: eicosenoic Source: Teesdalia 22:1 erucic 24:1 nervonic Cardamine Industrial Partnerships What we need to achieve together: •Identify & understand industry demand: needs, characteristics, trends •Establish applied research collaborations: oIdentify partners with complementary R&D for developing valueadded products oForm strong collaboration and together take research from the lab to the market 28 Thank you Elizabeth-France Marillia Scientist Tel: 306-975-5282 Elizabeth.marillia@nrc-cnrc.gc.ca www.nrc-cnrc.gc.ca 29 David C. Taylor Laurel O’ Connor Scientist Client Relationship Leader Tel: 306-975-5270 Tel: 306-975-4573 David.taylor@nrc-cnrc.gc.ca Laurel.oconnor@nrc-cnrc. gc.ca